Movement Alert|IBM Falls 3.12% in Regular Trading, Oppenheimer Withdraws $350 Target Price Amid Continued Earnings Shock Fallout

Market Focus07-16 22:17

On July 16, IBM declined 3.12% in regular trading, trading at $205.75/share with turnover of $10.02 billion. The drop reflects continued selling pressure following Oppenheimer's downgrade and the aftershock of IBM's historic single-day collapse earlier this week.

Oppenheimer downgraded IBM from Outperform to Peer Perform and withdrew its $350 price target, citing that double-digit software growth through 2027 faces significant challenges. The downgrade came after IBM suffered its largest single-day decline since at least 1968, plunging 25% after releasing preliminary Q2 results showing revenue of $172 billion, up only 1% year-over-year and well below the consensus estimate of approximately $179 billion. Infrastructure revenue fell 7%, software growth decelerated to just 5%, and consulting posted zero growth. Management attributed the shortfall to clients redirecting capital expenditures toward servers, storage, and memory hardware amid AI-driven supply constraints, squeezing software and traditional infrastructure budgets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment